4//SEC Filing
WORLAND STEPHEN T 4
Accession 0000950170-24-061593
CIK 0001828522other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:00 PM ET
Size
5.4 KB
Accession
0000950170-24-061593
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2024-05-15$1.68/sh+1,806$3,039→ 12,494 total
Holdings
- 22,493(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:00 PM ET
- Size
- 5.4 KB